On Progress in Surgical Treatment of Lung Cancer

Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v3i2.819

Yaoxing Xiao, Dongyu Zang

Guangzhou Red Cross Hospital Affiliated to Jinan University, Guangzhou 510000, Guangdong, China


Lung cancer, as one of the malignant tumors with the greatest impact on human health and life in the world, ranks first in the cancer mortality rate of urban population in China. As the first choice of surgery for early lung cancer, lobectomy is still the most commonly used clinical treatment. In this paper, lung cancer and surgery are taken as keywords, and the data are summarized and analyzed in the academic resource database of CNKI and Wanfang. 


lung cancer, treatment, operation


[1] Gao Ming, Zhou Qing, Wu Yilong. Changes in the treatment of inoperable stage Ⅲ non-small cell lung cancer in the immune era [J]. Evidence-Based Medicine, 2022,22(1):1-3,29.
[2] Liu Fenglin, Ma Wei. Analysis of clinical epidemiological and pathological characteristics of lung cancer patients [J]. China Medical Records, 2021,22(5):53-55.
[3] Ding Xinlei. Focusing on Lung Cancer Minimally Invasive Multidisciplinary Exchange and Wisdom — The 2nd China Forum on Lung Cancer Minimally Invasive Diagnosis and Treatment and Standardized Study Class on Thermal Ablation of Tumors in the Pulmonary Vagina [J]. China Medical Information Bulletin, 2018,33(9):24.
[4] Zhang Jianjun, Sun Yu, Li Guyi. Comparison of the efficacy of single-port thoracoscopic and three-port thoracoscopic lobectomy in the treatment of early stage lung cancer [J]. Chinese Journal of Clinicians, 2022,50(2):184-187.
[5] Lin Junfeng. Comparison of the effect of thoracoscopic lobectomy and segmentectomy in the treatment of early lung cancer [J]. Chinese and Foreign Medical Research, 2018,16(9):52-54.
[6] Liang Hongliang, Li Zilin, Dong Xiaochao, et al. Application of cardiopulmonary bypass technology in extended resection of locally advanced non-small cell lung cancer [J]. Chinese Journal of Cardiovascular Circulation, 2021,19(6):347-350.
[7] Liu Yilan, Cheng Yingying. Observation on the effect of rapid rehabilitation in lung cancer patients undergoing pneumonectomy [J]. China Health Standards Administration, 2019,10(19):152-154.
[8] Yang Yongpo, Dong Xiaoqi, Wang Junliang. Effects of thoracoscopic surgery on serum inflammatory factors and pain stress indicators in patients with non-small cell lung cancer [J]. Journal of Practical Cancer, 2022,37(3):425-427.
[9] Li Xuchi, Zhou Tao, Li Long. To explore the efficacy and safety of video-assisted thoracoscopic minimally invasive surgery in the treatment of elderly patients with non-small cell lung cancer [J]. Guizhou Medicine, 2021,45(5):777-778.
[10] Zhang Chunning, Li Chaoming, Li Mingyao, et al. Effects of minimally invasive cryoablation on tumor markers, immune function and prognosis in patients with advanced non-small cell lung cancer [J]. Journal of Huazhong University of Science and Technology (Medical Edition), 2021,50(1):67-71,76.
[11] Liu Haiyan, Chen Jun, Song Jian, et al. Effect of radiofrequency ablation combined with EGFR-TKIs in the treatment of EGFR-mutant lung cancer and observation of Th1/Th2 cell immunity [J]. Journal of Beichuan Medical College, 2020,35(5):783-786.
[12] Zhou Jing, Xia Hongxiang, Mao Changmin, et al. Comparison of the effects of Leonardo's robot and thoracoscopic surgery on the short-term curative effect, postoperative nutritional level and immune function of patients with radical lung cancer surgery [J]. Journal of Clinical and Experimental Medicine, 2022,21(3):303-307.
[13] Chai Xinchun, Xu Shiguang, Liu Bo, et al. Comparative analysis of the short-term efficacy of Leonardo's robot and video-assisted thoracoscopic segmentectomy for stage IA non-small cell lung cancer [J]. Chinese Journal of Thoracic and Cardiovascular Surgery, 2021,37(11):644-648.

Copyright © 2022 Yaoxing Xiao, Dongyu Zang

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License